Alpha 2.0
Login Register
» Authors » R Mason

R Mason

Explore the profile of R Mason including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 240
Citations 1960
Followers 0
Related Specialties
Neurology
General Surgery
Pharmacology
Top 10 Co-Authors
P A Reynolds
C A Marsden
W Kratzer
V G Wilson
K A Eaton
J Tudyka
J G Wechsler
F G Cunningham
K Hermsmeyer
M K Mundey
Published In
Neurosci Lett
Br Dent J
Exp Brain Res
Dis Esophagus
J Physiol
Affiliations
Soon will be listed here.
Recent Articles
1.
Characterizing the multi-dimensional reaction dynamics of dihalomethanes using XUV-induced Coulomb explosion imaging
Walmsley T, Unwin J, Allum F, Bari S, Boll R, Borne K, et al.
J Chem Phys . 2023 Oct; 159(14). PMID: 37823458
Site-selective probing of iodine 4d orbitals at 13.1 nm was used to characterize the photolysis of CH2I2 and CH2BrI initiated at 202.5 nm. Time-dependent fragment ion momenta were recorded using...
2.
Efficacy of immune checkpoint inhibitors for the treatment of advanced melanoma in patients with concomitant chronic lymphocytic leukemia
Cass S, Tobin J, Seo Y, Gener-Ricos G, Keung E, Burton E, et al.
Ann Oncol . 2023 Jul; 34(9):796-805. PMID: 37414216
Background: Immune checkpoint inhibitors (ICIs) have revolutionized the management of advanced melanoma (AM). However, data on ICI effectiveness have largely been restricted to clinical trials, thereby excluding patients with co-existing...
3.
Time-resolved relaxation and fragmentation of polycyclic aromatic hydrocarbons investigated in the ultrafast XUV-IR regime
Lee J, Tikhonov D, Chopra P, Maclot S, Steber A, Gruet S, et al.
Nat Commun . 2021 Oct; 12(1):6107. PMID: 34671016
Polycyclic aromatic hydrocarbons (PAHs) play an important role in interstellar chemistry and are subject to high energy photons that can induce excitation, ionization, and fragmentation. Previous studies have demonstrated electronic...
4.
Evidence for changing intimate partner violence safety planning needs as a result of COVID-19: results from phase I of a rapid intervention
Metheny N, Perri M, Velonis A, Kamalanathan J, Hassan M, Buhariwala P, et al.
Public Health . 2021 Apr; 194:11-13. PMID: 33845272
Objectives: The aim of the study was to examine the need for modified safety planning strategies in response to COVID-19-related increases in intimate partner violence (IPV) as the initial phase...
5.
Understanding the impact of COVID-19 on youth sport in Australia and consequences for future participation and retention
Elliott S, Drummond M, Prichard I, Eime R, Drummond C, Mason R
BMC Public Health . 2021 Mar; 21(1):448. PMID: 33673812
Background: COVID-19 continues to represent the single biggest challenge to contemporary community sport globally. Compliance with social distancing policies, strict return-to-play protocols, and COVID-19 specific training has, perhaps, forever changed...
6.
Congenital oral vascular hamartoma in a Jersey cross calf
Martin B, Mason R, Lawrence K, Castillo-Alcala F
N Z Vet J . 2020 Sep; 69(2):131-133. PMID: 32928059
No abstract available.
7.
The psychological functioning of children with epidermolysis bullosa and its relationship with specific aspects of disease
Soon K, Mason R, Martinez A, Mellerio J
Br J Dermatol . 2019 Oct; 182(3):789-790. PMID: 31587254
No abstract available.
8.
Discontinuation of anti-PD-1 antibody therapy in the absence of disease progression or treatment limiting toxicity: clinical outcomes in advanced melanoma
Jansen Y, Rozeman E, Mason R, Goldinger S, Geukes Foppen M, Hoejberg L, et al.
Ann Oncol . 2019 Mar; 30(7):1154-1161. PMID: 30923820
Background: Programmed cell death protein 1 (PD-1) blocking monoclonal antibodies improve the overall survival of patients with advanced melanoma but the optimal duration of treatment has not been established. Patients...
9.
iSurgery: a contemporary simulator for surgical education
Tahir M, Davis C, Mason R
Ann R Coll Surg Engl . 2014 Oct; 96(8):633-4. PMID: 25350204
No abstract available.
10.
CT Tumoral Heterogeneity as a Prognostic Marker in Primary Esophageal Cancer Following Neoadjuvant Chemotherapy
Yip C, Davnall F, Kozarski R, Landau D, Mason R, Lagergren J, et al.
Pract Radiat Oncol . 2014 Mar; 3(2 Suppl 1):S3. PMID: 24674540
No abstract available.